Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity.
about
Role of ENPP1 on adipocyte maturationIs the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?Antioxidant Activity of γ-Oryzanol: A Complex Network of InteractionsOrphan nuclear receptors and the regulation of nutrient metabolism: understanding obesityComparative Analyses of QTLs Influencing Obesity and Metabolic Phenotypes in Pigs and HumansAdipose tissue mass is modulated by SLUG (SNAI2)DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytesLipocalin prostaglandin D synthase and PPARγ2 coordinate to regulate carbohydrate and lipid metabolism in vivoAdipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice.PPARgamma deficiency results in reduced lung elastic recoil and abnormalities in airspace distribution.Ppargamma2 is a key driver of longevity in the mouse.PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma.PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes.17β-Estradiol inhibition of PPARγ-induced adipogenesis and adipocyte-specific gene expressionActivation of PPAR gamma induces profound multilocularization of adipocytes in adult mouse white adipose tissues.Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.Disruption of inducible 6-phosphofructo-2-kinase ameliorates diet-induced adiposity but exacerbates systemic insulin resistance and adipose tissue inflammatory response.PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice.Myeloid cell-specific disruption of Period1 and Period2 exacerbates diet-induced inflammation and insulin resistanceNitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligandAssociation of the Pro12Ala Polymorphism with the Metabolic Parameters in Women with Polycystic Ovary Syndrome.Involvement of inducible 6-phosphofructo-2-kinase in the anti-diabetic effect of peroxisome proliferator-activated receptor gamma activation in mice.PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues.Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes.Transcriptional targets in adipocyte biologyPalmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice.Synthesis of N-(6-(4-(Piperazin-1-yl)phenoxy)pyridin-3-yl)benzenesulfonamide Derivatives for the Treatment of Metabolic Syndrome.Targeting steroid receptor coactivator 1 with antisense oligonucleotides increases insulin-stimulated skeletal muscle glucose uptake in chow-fed and high-fat-fed male ratsThe peroxisome proliferator-activated receptor-gamma regulates murine pyruvate carboxylase gene expression in vivo and in vitro.The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoformOncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program.Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes.Mechanical strain regulates osteogenic and adipogenic differentiation of bone marrow mesenchymal stem cellsNedd4 haploinsufficient mice display moderate insulin resistance, enhanced lipolysis, and protection against high-fat diet-induced obesity.Genetic manipulations of PPARs: effects on obesity and metabolic disease.Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality.Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.The orphan nuclear receptor small heterodimer partner is required for thiazolidinedione effects in leptin-deficient mice.Maternal PPAR gamma protects nursing neonates by suppressing the production of inflammatory milk
P2860
Q24293330-80E8A608-0503-4929-8248-64993FCFEB48Q26739984-891ECAD6-8B9A-4794-92E8-1AB221A49B1DQ26741624-D20DB1E2-193F-4504-9456-7397ED0D8973Q26823819-717E348E-AC42-4C18-AC32-D20C62AF781EQ27319251-F03572B6-7D65-4114-A274-029F51708D2FQ28504849-A1654D33-3E69-4789-99EB-1A6738348152Q28585713-518AF394-147F-42FC-9F36-EE48B13BAC9CQ28727526-76BBD751-F7F0-47F0-AA6A-EE75D6B50CC2Q30480233-ACBAB6A8-3252-4F5B-BC27-B0C6C19EDFA9Q30480970-18859967-DA69-48D9-AB2C-31A68C39299EQ30975227-BD587C9A-E098-44C9-B0D2-8D6067E1FCF1Q33283063-FC246F7E-A475-4463-A271-65CC6D500145Q33347137-D500EDD4-BA70-401F-9429-2A1018C5B2A4Q33461994-773ED4FD-0A8C-4A64-A44B-9A4BE2198A11Q33565712-F68CAC26-6DE3-43E4-9028-8BC964449E77Q33575775-2DFA31E0-543B-47DE-802B-557E0DD96E1BQ33653171-35902C29-5FE6-4359-A035-7B930923E52BQ33662075-1E031742-2DB6-40EF-927A-FA47C871C4F9Q33685586-20A35EC6-D63E-40F1-9173-5A8AB0593EAFQ33718549-85EDF579-F30F-418E-96B1-A3B84B14DEF9Q33849597-767529E5-69D1-4983-B0A7-654956DB5C4FQ33889546-3626A002-D9A7-4155-A3AE-8C167CBD4AD9Q34025180-CBFA01E9-F326-4F44-91A8-1C0425E984E5Q34143718-D7A93104-945E-4113-BDB4-1205D5EEDD83Q34179518-F50ADBF3-C89F-4686-92B4-ADC13014D581Q34192987-DFF853AB-0069-4473-A699-6AAF47402B83Q34328111-D02998CB-67CA-4B98-9524-5B451BB640E5Q34393303-690D589F-3596-40AE-93A6-7F835A0F5E99Q34439547-FD49E7B9-8A33-4AA5-B015-588DF459E5D6Q35004507-E00CAD36-0598-4533-AA7D-F9C144BFEA70Q35004514-C420EFCD-7530-4F7A-A361-228EE105AEF2Q35215073-2184BDA4-914F-4FA2-91D9-EFBF1DA87810Q35222158-17A1EE52-5E52-40DE-9A2A-BFA6D9C89142Q35438238-400C7638-E9C4-4D86-B499-C1A3DA450E59Q35442337-E6C0813D-E82C-48C2-89DD-495C7175F5BEQ35623601-03D0C6A9-AC6C-4559-B694-50AA9EEAA9CEQ35629015-A989104E-7BC8-4AE5-BB84-ABD688FBCA40Q35636191-D35707F7-D198-4A63-B260-5FD850E7F215Q35810498-790C2956-E9EA-45B1-BA67-242F6AFFA53CQ35917057-2E441C79-C16D-4384-B275-16665CAB07AA
P2860
Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Selective disruption of PPARga ...... issue and insulin sensitivity.
@en
type
label
Selective disruption of PPARga ...... issue and insulin sensitivity.
@en
prefLabel
Selective disruption of PPARga ...... issue and insulin sensitivity.
@en
P2093
P2860
P356
P1476
Selective disruption of PPARga ...... tissue and insulin sensitivity
@en
P2093
Chen Xiong
Donna Floyd
Jian Liang
Jifeng Zhang
P2860
P304
10703-10708
P356
10.1073/PNAS.0403652101
P407
P50
P577
2004-07-12T00:00:00Z